Literature DB >> 15193870

Study on the expression of angiotensin II (ANG II) receptor subtype 1 (AT1R) in the placenta of pregnancy-induced hypertension.

L Thapa1, C M He, H P Chen.   

Abstract

OBJECTIVE: To study the expression of angiotensin II (ANG II) receptor subtype 1 (AT(1)R) in the human placenta with pregnancy-induced hypertension (PIH).
METHODS: Immunohistochemistry was used to detect the expression of AT(1)R in placental tissues of 30 patients with PIH and 10 patients with normal pregnancies (control group). The PIH tissues were further divided into 3 groups: mild PIH group, moderate PIH group and severe PIH group. Each group consisted of 10 patients. A high-resolution pathological image analysis system (HPIAS-1000) was used to determine the quantity of AT(1)R expression.
RESULTS: The integral optical density and area of staining in the syncytiotrophoblast (STB) layer and villous endothelium of the placenta were significantly increased in PIH patients, in the moderate and severe PIH groups, as compared with the control group (P < 0.05), indicating that the expression of AT(1)R was highly increased in PIH. However, there was no significant difference between normal pregnancy and the mild PIH group (P > 0.05). Furthermore, statistically significant differences in AT(1)R expression were observed between mild, moderate and severe PIH groups (P < 0.05).
CONCLUSION: The expression of AT(1)R is statistically significantly increased in the STB layer and villous endothelium of human placenta with PIH. Expression increases with the severity of the disease. Increased expression may be involved in the pathogenesis of PIH.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15193870     DOI: 10.1016/j.placenta.2004.01.026

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  7 in total

1.  Ku80 is differentially expressed in human lung carcinomas and upregulated in response to irradiation in mice.

Authors:  Jian Ye; Zhenyi Ren; Qing Gu; Limin Wang; Jiaoli Wang
Journal:  DNA Cell Biol       Date:  2011-06-11       Impact factor: 3.311

2.  Aldosterone and renin concentrations were abnormally elevated in a cohort of normotensive pregnant women.

Authors:  Valentina Pastén; Cristian A Carvajal; Alejandra Tapia-Castillo; Carlos E Fardella; Andrea Leiva
Journal:  Endocrine       Date:  2021-11-26       Impact factor: 3.633

3.  Analysis of sensitivity and specificity: precise recognition of neutrophils during regeneration of contused skeletal muscle in rats.

Authors:  Jiajia Niu; Guoshuai An; Zhen Gu; Peng Li; Qiqing Liu; Rufeng Bai; Junhong Sun; Qiuxiang Du
Journal:  Forensic Sci Res       Date:  2020-03-19

4.  Activation of local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia.

Authors:  Lauren Anton; David C Merrill; Liomar A A Neves; Kathryn Stovall; Patricia E Gallagher; Debra I Diz; Cheryl Moorefield; Courtney Gruver; Carlos M Ferrario; K Bridget Brosnihan
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

5.  Biodegradable and biocompatible cationic polymer delivering microRNA-221/222 promotes nerve regeneration after sciatic nerve crush.

Authors:  Jialin Song; Xueyang Li; Yingli Li; Junyi Che; Xiaoming Li; Xiaotian Zhao; Yinghui Chen; Xianyou Zheng; Weien Yuan
Journal:  Int J Nanomedicine       Date:  2017-06-02

Review 6.  A Narrative Review of the Renin-Angiotensin-Aldosterone System in the Placenta and Placental Bed of HIV Infected Women of African Ancestry with Preeclampsia.

Authors:  Shoohana Singh; Jagidesa Moodley; Olive Pearl Khaliq; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2021-08-20       Impact factor: 5.369

7.  A novel mechanism of angiotensin II-regulated placental vascular tone in the development of hypertension in preeclampsia.

Authors:  Qinqin Gao; Jiaqi Tang; Na Li; Xiuwen Zhou; Yongmei Li; Yanping Liu; Jue Wu; Yuxian Yang; Ruixiu Shi; Axin He; Xiang Li; Yingying Zhang; Jie Chen; Lubo Zhang; Miao Sun; Zhice Xu
Journal:  Oncotarget       Date:  2017-05-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.